Dublin, Feb. 25, 2026 (GLOBE NEWSWIRE) — The “Prefilled Syringe Fill Finish Manufacturing Market: Industry Trends and Global Forecasts – Distribution by Type of Therapeutic Area, Type of Syringe Barrel Material, Number of Barrel Chambers, Type of Drug Molecule, Scale of Operation and Key Geographical Regions” has been added to ResearchAndMarkets.com’s offering.
The global prefilled syringe fill finish manufacturing market, valued at USD 931 million this year, is set for impressive growth with a Compound Annual Growth Rate (CAGR) of 11.9% during the forecast period.
The report provides an in-depth market analysis, exploring key segments: therapeutic areas, syringe barrel materials, barrel chambers, drug molecule types, operation scales, and geographic regions. It evaluates market players based on establishment year, size, operations scale, headquarters location, fill/finish facilities, and syringe specifications. Detailed company profiles offer insights into service portfolios and recent developments.
The prefilled syringe, a crucial medication dispensing solution, has seen its usage triple over the last decade, primarily due to the rise in development of parenteral drugs. These syringes are favored for their numerous advantages over traditional systems, such as minimized dosing errors, enhanced patient adherence, and reduced microbial contamination risk. These benefits have bolstered their adoption in chronic disease treatment requiring frequent medication administration.
The increased self-medication trend and market demand for prefilled combination drugs have necessitated the outsourcing of fill/finish operations, a result of technical challenges in managing syringe fill volumes. This has shifted the industry towards outsourcing, driving market growth. Demand for safer, user-friendly drug delivery technologies and efforts to enhance cost efficiency are anticipated to further propel the market.
Comprehensive analysis of the market reveals substantial expansion opportunities. Key findings include: over 100 global entities offering contract fill/finish services, half of which are large-scale companies; presence of well-established players across geographies; and most providers have capabilities for both small molecules and biologics fill/finish services, although about 20% specialize in only biologics. Companies are widening their reach and capacities through partnerships and geographic expansion, particularly in emerging regions like Asia.
Large service providers dominate the market’s fill/finish capacity for prefilled syringes, controlling approximately 80% of global capacity. Europe and North America remain prime regions for partnerships, with nearly 70 prefilled syringes produced by major companies capable of using both glass and plastic syringe barrels. The outsourcing trend is predicted to persist, sustaining market growth at an annualized rate exceeding 11.9% in the short to midterm, with long-term opportunities dispersed across different product types, scales, and areas.
Key Questions Answered in This Report
- How many companies are engaged in this market?
- Which are the leading companies?
- What factors influence market evolution?
- What are the current and future market sizes?
- What is the CAGR?
- How will market opportunities distribute across segments?
Players in the Prefilled Syringe Fill Finish Manufacturing Market
- Ajinomoto Bio-Pharma Services
- AMRI
- BioPharma Solutions
- Emergent BioSolutions
- Patheon (a Thermo Fisher Scientific Company)
- Consort Medical
- EVER Pharma
- GlaxoSmithKline
- IDT Biologika
- Rentschler Biopharma
- Siegfried
- Vetter Pharma
- Biocon
- Intas Pharmaceuticals
- Kemwell Biopharma
- Square Pharmaceuticals
Full List of Companies Featured
- ABB
- Abbott
- AbbVie
- AbbVie Contract Manufacturing
- Ablynx
- Accord Healthcare
- Adamis Pharmaceuticals
- Adimmune
- Aguettant
- AJ Biologics
- Ajinomoto Bio-Pharma Services
- Akron Biotech
- Akums Drugs & Pharmaceuticals
- Alanza
- Alcami
- Alder BioPharmaceuticals
- Alfasigma
- Alkermes
- Alvogen
- Alvotech
- Amega Biotech
- Amgen
- Amneal Deutschland GmbH
- AMRI
- APL
- Apobiologix
- Aptar Pharma
- Aristopharma
- Asarina Pharma
- AstraZeneca
- Austrianova
- Automated Systems of Tacoma
- Axcellerate Pharma
- Bahrain Pharma
- Baxter
- Becton Dickinson
- Berkshire Sterile Manufacturing
- Bespak
- Beximco Pharma
- Bill & Melinda Gates Medical Research Institute
- Bio Elpida
- Biocad
- Biocon
- BioConnection
- Biogen
- Bioinova
- Biomedical Advanced Research and Development Authority
- BioPharma Solutions
- Biotech Vision Care
- BirgiMefar
- Boehringer Ingelheim
- Boehringer Ingelheim BioXcellence
- Bone Therapeutics
- Braeburn Pharmaceuticals
- Bristol-Myers Squibb
- Bryllan
- CARBOGEN AMCIS
- Catalent Biologics
- Celltrion
- Cenexi
- Centrexion Therapeutics
- Cerium Pharmaceuticals
- Chugai Pharmaceuticals
- CinnaGen
- Ciron Drugs and Pharmaceutical
- Clover Biopharmaceuticals
- Coalition for Epidemic Preparedness Innovations
- Cobra Biologics
- Coherus Biosciences
- Combino Pharm
- Consort Medical
- Cook Pharmica
- Corden Pharma
- Dalton Pharma Services
- Delpharm
- DENSO
- Dhruv Life sciences
- DM Bio
- Dynavax Technologies
- EirGen Pharma
- Eli Lilly
- Emcure Pharmaceuticals
- EMD Serono
- Emergent BioSolutions
- Eurofins BioPharma
- European Medical Contract Manufacturing
- Ever Pharma
- Evotec
- ExCellThera
- FACET
- FANUC America
- Foresee Pharmaceutical
- Fresenius Kabi
- Fresenius Kabi Contract Manufacturing
- Fujifilm
- Gadea Pharmaceutical Group
- GC Pharma
- GeneDesign
- Genentech
- Generon (Shanghai)
- Genmab
- Genovior Biotech
- Gerresheimer
- Gland Pharma
- GlaxoSmithKline
- GP Pharm
- Grand River Aseptic Manufacturing
- Gulf Biotech
- Hanmi Pharmaceutical
- Health Biotech
- Healthcare Pharmaceuticals
- Heron Therapeutics
- Hetero Drugs
- Hetero Healthcare
- Hisun Pharmaceuticals USA
- IDEO
- IDT Biologika
- Il-Yang Pharm
- Injectalia
- Intas Pharmaceuticals
- Integrity Bio
- Ipsen
- IRISYS
- Italfarmaco
- Janssen
- Johnson & Johnson
- Kawasaki Heavy Industries
- Kemwell Biopharma
- Keryx Biopharmaceuticals
- Kilitch Healthcare
- Kiniksa Pharmaceuticals
- KP Pharmaceutical Technology
- KUKA
- Kyowa Hakko Kirin
- Laboratorios SALVAT
- Leo Pharma
- Lifecore Biomedical
- LSNE Contract Manufacturing
- Lubrizol Life Science Health
- Lundbeck
- Lyell Immunopharma
- Marchesini Group
- Massman Automation Designs
- Medefil
- Medicago
- Merck
- Metrion Biosciences
- Mithra
- Mithra Pharmaceuticals
- Mitsubishi Electric
- Mitsubishi Gas Chemical
- Mitsubishi Tanabe Pharma
- Momenta Pharmaceuticals
- MorphoSys
- Mycenax Biotech
- National Institute of Allergy and Infectious Disease
- Nemus Bioscience
- Nipro
- Northway Biotechpharma
- Nova Laboratories
- Novartis
- Ology Bioservices
- OmniChem
- Ompi
- OMRON Industrial Automation
- Oncobiologics
- Oncotec Pharma Produktion
- “Opiant
- Pharmaceuticals”
- Otsuka Pharmaceutical
- Patheon
- PCI Pharma Services
- Pfizer
- Pfizer CentreOne
- Pfizer Injectables
- Pharmaceutics International
- Pierre Fabre
- Piramal Enterprises
- Pisa Farmaceutica
- Polpharma Biologics
- Praxis Pharmaceutical
- Precision Ocular Metrology
- PrimaPharma
- PYRAMID Laboratories
- Recipharm
- Regeneron
- Reliance Life Sciences
- Rentschler Biopharma
- RHEACELL
- Roche
- Rompharm
- Rovi CM
- Sabin Vaccine Institute
- SAFC
- Samsung Bioepis
- Samsung Biologics
- Sandoz
- Sanofi
- Saudi Biotech Manufacturing
- Schott
- Schott-Kaisha
- ScinoPharm
- Seiko Epson
- Selecta Biosciences
- Seqirus
- Sewa Medicals
- Shandong Pharmaceutical Glass
- Shandong Weigao
- Sharp
- Shire
- SHL Group
- Siegfried
- Singota Solutions
- SOBI
- Sovereign Pharma
- Spectrum Pharmaceuticals
- Square Pharmaceuticals
- Staubli
- Stempeutics
- Sun Pharma
- Sunshine Health Products
- Swissfillon
- Symphogen
- Syngene
- Taisei Kako
- Taiyo Yakuhin
- Takeda
- Tanvex BioPharma
- Tekpak
- Terumo
- Teva Pharmaceutical
- The United States Department of Health and Human Services (HHS)
- Tolmar
- Transcoject
- TriPharm Services
- UCB Biopharma
- Unicep
- United States Army Medical Materiel Development Activity
- Universal Robots
- University of California
- US Department of Health and Human Services
- USV
- Valeant Pharmaceuticals
- Vanrx Pharmasystems
- Vaxart
- VELIT Biopharmaceuticals
- Vetter Pharma
- Vitaeris
- VxP Biologics
- West Pharmaceuticals
- Wockhardt
- Yaskawa Electric
- YL Biologics
- Zen Pharma
- Zhejiang Huahai Pharmaceutical
For more information about this report visit https://www.researchandmarkets.com/r/9r13rf
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
